Susan Hasty, Publisher
Table of Contents . . . December 1st, 2008
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Clinical Trials Week | Other Publications
Ardea Biosciences, Inc. - Ardea Biosciences Announces Progress of Clinical Development Programs and Reports Third Quarter and Year-to-Date 2008 Financial Results
Epeius Biotechnologies - Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma: Phase I/II & Confirmatory Phase II Studies
Radius Health - Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million
Brain Metastasis - Studies from Royal Marsden Hospital yield new information about brain metastasis
Cancer - Investigators at Addenbrooke's Hospital release new data on cancer
Cancer - Researchers from Kyorin University, Medical Department detail findings in cancer
Cancer Vaccines - Research on cancer vaccines reported by A. Berntsen et al
Enzyme Research - Research from GlaxoSmithKline, Collegeville yields new findings on enzyme research
Melanoma - Research on melanoma described by scientists at University of Virginia
Non-Hodgkin Lymphoma - Investigators at Mayo Clinic release new data on non-hodgkin lymphoma
Tuberculosis - Researchers at Johns Hopkins University have published new data on tuberculosis
Breast Cancer Prognosis - Findings in breast cancer prognosis reported from J.Y. Pierga and co-researchers
Breast Cancer Therapy - Study findings on breast cancer therapy are outlined in reports from T.H. Luu and colleagues
Cancer Clinical Trial - New cancer clinical trial findings from SAIC-Frederick, Inc. published
Clinical Trial Research - Research reports from University of Sao Paulo, Department of Restorative Dentistry provide new insights into clinical trial research
Colon Cancer Therapy - New findings in colon cancer therapy described from Stanford University, Department of Medicine
Follicular Lymphoma Immunotherapy - Researchers from University of Pittsburgh, Department of Medicine publish findings in follicular lymphoma immunotherapy
HIV/AIDS Clinical Trial - New HIV/AIDS clinical trial study findings recently were reported by researchers at Columbia University, Department of Medicine
Life Sciences - Studies from University of Texas, Health Science Center add new findings in the area of life sciences
Melanoma Therapy - Reports outline melanoma therapy study results from N. Penel et al
Monoclonal Antibodies - Recent findings from Duke University, Department of Surgery highlight research in monoclonal antibodies
Tuberculosis Vaccines - Reports summarize tuberculosis vaccines study results from St. Louis University, Center for Vaccine Development
Arete Therapeutics Inc. - Arete Therapeutics Closes $16.7 Million in Final Tranche of Its Series a Financing
Avexa Limited - Avexa Presents Data from Apricitabine and Antibacterial Programs at two International Conferences
Bavarian Nordic A/S - Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission of Important IMVAMUNE Data to the U.S. Health Authorities
Biotechnology Business - Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission of Important IMVAMUNE(R) Data to the U.S. Health Authorities
Breast Cancer - Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
Clinical Trial Research - Bradmer to present poster on progression free survival and overall survival data from Neuradiab(TM) Phase II trials at Society for Neuro-Oncology Meeting
Clinical Trial Research - Duska Therapeutics Applies for Phase 3 Special Protocol Assessment
Leukemia - Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351
Lower Back Pain - Neuromed Completes Enrollment for Phase 3 Chronic Low Back Pain Clinical Trial of NMED-1077
Marketing and Licensing Agreements - Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting
Monoclonal Antibodies - PacificGMP and Actinium Pharmaceuticals Announce Agreements for cGMP Antibody Manufacturing and Stability Testing
Non-Small Cell Lung Cancer - Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
Obesity and Diabetes - Metabolex Announces Positive Results from Phase 2 Clinical Trial of MBX-8025
Schizophrenia - Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia
Vical Incorporated - Vical Announces Strategic Restructuring and Staff Reduction
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.